Gland Pharma Limited — Others, 22-05-2025: Options to purchase securities

Gland Pharma has announced a board meeting approving the grant of 843,685 employee stock options to 123 employees under its ESOP 2025 scheme. Of these, 556,832 options are priced at INR 773.30 each, and 286,853 options are at INR 1 (face value). Vesting will occur over three years in tranches: 34% after one year, then 33% each in the following two years, with options exercisable within two years after vesting. This move aims to align employee incentives with long-term shareholder value.